Salomon & Ludwin’s NeoGenomics NEO Stock Holding History

Salomon & Ludwin’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-998	Closed	-$12.1K	–	2159
2025 Q4	$12.1K	Sell	998 -1	-0.1%	-$11	﹤0.01%	1320
2025 Q3	$9.09K	Buy	+999	New	+$7K	﹤0.01%	1382

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Salomon & Ludwin's NEO Position: Q1 2026 in Review

Salomon & Ludwin sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 998 shares — an estimated $12.1K sold.

Salomon & Ludwin first reported a position in NEO in Q3 2025 and held it in 2 quarters. The position peaked at $12.1K in Q4 2025. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

Salomon & Ludwin reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
Salomon & Ludwin sold 998 NeoGenomics shares in Q1 2026, an estimated $12.1K.
Salomon & Ludwin first reported a position in NeoGenomics in Q3 2025 and held it in 2 quarters.
Salomon & Ludwin's NeoGenomics position peaked at $12.1K in Q4 2025.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.